Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Boehringer Ingelheim is one of the world’s leading research-oriented pharmaceutical companies. The clinical pipeline is constantly being further developed, and Boehringer Ingelheim expects new ...

The clinical pipeline is constantly being further developed, and Boehringer Ingelheim expects new approvals also in oncology in the coming years. An important investment in the future is the new ...

Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost ... Boehringer’s capital investments reached EUR 6.0 billion Boehringer Ingelheim is one of the ...

Boehringer’s capital investments reached EUR 6.0 billion Boehringer Ingelheim is one of the world's leading research-oriented pharmaceutical companies. The clinical pipeline is constantly being ...